Minerva Surgical Past Earnings Performance
Past criteria checks 0/6
Minerva Surgical has been growing earnings at an average annual rate of 9.4%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 6% per year.
Key information
9.4%
Earnings growth rate
113.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 6.0% |
| Return on equity | -165.1% |
| Net Margin | -64.7% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Is There An Opportunity With Minerva Surgical, Inc.'s (NASDAQ:UTRS) 44% Undervaluation?
Aug 11
Minerva downgraded at JPMorgan citing lowered guidance
Aug 10Minerva Surgical, Inc. (NASDAQ:UTRS) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 10Minerva Surgical - Uterine Play For Sale
Nov 02Revenue & Expenses BreakdownBeta
How Minerva Surgical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 52 | -33 | 56 | 6 |
| 30 Jun 23 | 52 | -38 | 61 | 6 |
| 31 Mar 23 | 52 | -35 | 63 | 6 |
| 31 Dec 22 | 50 | -34 | 62 | 5 |
| 30 Sep 22 | 50 | -17 | 59 | 5 |
| 30 Jun 22 | 50 | -9 | 56 | 5 |
| 31 Mar 22 | 51 | -17 | 58 | 5 |
| 31 Dec 21 | 52 | -21 | 54 | 5 |
| 30 Sep 21 | 52 | -39 | 48 | 5 |
| 30 Jun 21 | 52 | -43 | 45 | 5 |
| 31 Mar 21 | 44 | -33 | 34 | 4 |
| 31 Dec 20 | 38 | -18 | 30 | 3 |
| 31 Dec 19 | 26 | -52 | 31 | 1 |
Quality Earnings: UTRS is currently unprofitable.
Growing Profit Margin: UTRS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: UTRS is unprofitable, but has reduced losses over the past 5 years at a rate of 9.4% per year.
Accelerating Growth: Unable to compare UTRS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: UTRS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: UTRS has a negative Return on Equity (-165.14%), as it is currently unprofitable.